Rchr
J-GLOBAL ID：201801017355801908
Update date: Jun. 08, 2020
YASUDA Soichiro
YASUDA Soichiro
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
International University of Health and Welfare School of Medicine
About International University of Health and Welfare School of Medicine
Search "International University of Health and Welfare School of Medicine"
Detailed information
Research field (1)：
Cardiology
Papers (21)：
C. Yasuda, S. Yasuda, H. Yamashita, J. Okada, T. Hisada, S. Sugiura. THE HUMAN ETHER-A-GO-GO-RELATED GENE (hERG) CURRENT INHIBITION SELECTIVELY PROLONGS ACTION POTENTIAL OF MIDMYOCARDIAL CELLS TO AUGMENT TRANSMURAL DISPERSION. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. 2015. 66. 4. 599-607
Jennifer Davis, Soichiro Yasuda, Nathan J. Palpant, Joshua Martindale, Tamara Stevenson, Kimber Converso, Joseph M. Metzger. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. 2012. 53. 3. 446-457
DeWayne Townsend, Soichiro Yasuda, Elizabeth McNally, Joseph M. Metzger. Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex. FASEB JOURNAL. 2011. 25. 9. 3106-3114
DeWayne Townsend, Immanuel Turner, Soichiro Yasuda, Joshua Martindale, Jennifer Davis, Michael Shillingford, Joe N. Kornegay, Joseph M. Metzger. Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. JOURNAL OF CLINICAL INVESTIGATION. 2010. 120. 4. 1140-1150
Townsend D, Yasuda S, Chamberlain J, Metzger JM. Cardiac consequences to skeletal muscle-centric therapeutics for Duchenne muscular dystrophy. Trends Cardiovasc Med. 2009. 19. 50-55
ｍore...
Patents (1)：
Compositions and methods for treating and preventing cardiomyopathy and heart disease
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
